.png)
Resolian is a leading global Contract Research Organization (CRO) providing specialized services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetic (DMPK), and GMP CMC analytical and materials science. Comprised of the former Alliance Pharma Inc, Drug Development Solutions Ltd, and Denali Medpharma labs and powered by a team of more than 500 experts across the US, UK, Australia, and China, Resolian supports pharma and biotech companies’ programs throughout the entire drug development continuum.
Resolian's specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, and drug metabolism. These solutions are delivered through Resolian's dedicated global laboratories, equipped with state-of-the-art technology and ready to meet client needs for preclinical studies as well as regional or global clinical programs.
We are committed to delivering high-quality results and ensuring compliance with regulatory requirements. Its team of experts works closely with clients to develop customized solutions for each specific program requirements. A trusted partner for pharmaceutical and biotech companies seeking specialized support in drug development, Resolian's extensive expertise, advanced technology, and commitment to quality combine to fully deliver for companies of all sizes and at any stage of the drug development process.